Fingerprint
Dive into the research topics of 'Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Massimiliano Lanzafame, Emanuela Lattuada, Fabio Rigo, Stefano Nicole, Giulia Cucchetto, Sandro Vento
Research output: Contribution to journal › Letter › peer-review